190 related articles for article (PubMed ID: 16388852)
1. Association between Enterococcus bacteraemia and death in neutropenic patients with haematological malignancies.
Todeschini G; Tecchio C; Borghero C; D'Emilio A; Pegoraro E; de Lalla F; Benedetti P; Spolaore P; Pellizzer G
J Infect; 2006 Oct; 53(4):266-73. PubMed ID: 16388852
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and clinical outcome of enterococcal bacteraemia in an acute care hospital.
Poh CH; Oh HM; Tan AL
J Infect; 2006 May; 52(5):383-6. PubMed ID: 16203039
[TBL] [Abstract][Full Text] [Related]
3. Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia.
Garbutt JM; Ventrapragada M; Littenberg B; Mundy LM
Clin Infect Dis; 2000 Mar; 30(3):466-72. PubMed ID: 10722429
[TBL] [Abstract][Full Text] [Related]
4. Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection.
DiazGranados CA; Jernigan JA
J Infect Dis; 2005 Feb; 191(4):588-95. PubMed ID: 15655783
[TBL] [Abstract][Full Text] [Related]
5. Short-term mortality of bacteraemia in elderly patients with haematological malignancies.
Nørgaard M; Larsson H; Pedersen G; Schønheyder HC; Rothman KJ; Sørensen HT
Br J Haematol; 2006 Jan; 132(1):25-31. PubMed ID: 16371016
[TBL] [Abstract][Full Text] [Related]
6. Haematological malignancies--a predictor of a poor outcome in patients with bacteraemia.
Nørgaard M; Larsson H; Pedersen G; Schønheyder HC; Sørensen HT
J Infect; 2006 Sep; 53(3):190-8. PubMed ID: 16352338
[TBL] [Abstract][Full Text] [Related]
7. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
Peralta G; Sánchez MB; Garrido JC; De Benito I; Cano ME; Martínez-Martínez L; Roiz MP
J Antimicrob Chemother; 2007 Oct; 60(4):855-63. PubMed ID: 17644532
[TBL] [Abstract][Full Text] [Related]
8. Pseudomonas aeruginosa bacteraemia. Is pancreatobiliary disease a risk factor?
Chen SC; Lawrence RH; Byth K; Sorrell TC
Med J Aust; 1993 Nov; 159(9):592-7. PubMed ID: 8232033
[TBL] [Abstract][Full Text] [Related]
9. Risk of bacteraemia and mortality in patients with haematological malignancies.
Nørgaard M; Larsson H; Pedersen G; Schønheyder HC; Sørensen HT
Clin Microbiol Infect; 2006 Mar; 12(3):217-23. PubMed ID: 16451407
[TBL] [Abstract][Full Text] [Related]
10. Enterococcal bacteraemia in a tertiary care hospital of North India.
Mohanty S; Kapil A; Das BK
J Indian Med Assoc; 2005 Jan; 103(1):31-2, 34, 36-7. PubMed ID: 16008327
[TBL] [Abstract][Full Text] [Related]
11. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
[TBL] [Abstract][Full Text] [Related]
12. Attributable mortality rate and duration of hospital stay associated with enterococcal bacteremia.
Caballero-Granado FJ; Becerril B; Cuberos L; Bernabeu M; Cisneros JM; Pachón J
Clin Infect Dis; 2001 Feb; 32(4):587-94. PubMed ID: 11181122
[TBL] [Abstract][Full Text] [Related]
13. Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization.
Cheah AL; Spelman T; Liew D; Peel T; Howden BP; Spelman D; Grayson ML; Nation RL; Kong DC
Clin Microbiol Infect; 2013 Apr; 19(4):E181-9. PubMed ID: 23398607
[TBL] [Abstract][Full Text] [Related]
14. Incidence, clinical characteristics and 30-day mortality of enterococcal bacteraemia in Denmark 2006-2009: a population-based cohort study.
Pinholt M; Ostergaard C; Arpi M; Bruun NE; Schønheyder HC; Gradel KO; Søgaard M; Knudsen JD;
Clin Microbiol Infect; 2014 Feb; 20(2):145-51. PubMed ID: 23647880
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center.
Lodise TP; McKinnon PS; Tam VH; Rybak MJ
Clin Infect Dis; 2002 Apr; 34(7):922-9. PubMed ID: 11880957
[TBL] [Abstract][Full Text] [Related]
16. Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia.
Peel T; Cheng AC; Spelman T; Huysmans M; Spelman D
Clin Microbiol Infect; 2012 Apr; 18(4):388-94. PubMed ID: 21848977
[TBL] [Abstract][Full Text] [Related]
17. [Bacteremia due to vancomycin-resistant enterococci in neutropenic cancer patients].
Marron A; Carratalà J; Ayats J; Fernández de Sevilla A; Domínguez MA; Liñares J; Gudiol F
Med Clin (Barc); 1998 Dec; 111(20):761-4. PubMed ID: 9922964
[TBL] [Abstract][Full Text] [Related]
18. Systemic inflammatory response syndrome in nosocomial bloodstream infections with Pseudomonas aeruginosa and Enterococcus Species: comparison of elderly and nonelderly patients.
Marra AR; Bar K; Bearman GM; Wenzel RP; Edmond MB
J Am Geriatr Soc; 2006 May; 54(5):804-8. PubMed ID: 16696747
[TBL] [Abstract][Full Text] [Related]
19. [Study of a cohort of patients with Enterococcus spp. Bacteraemia. Risk factors associated to high-level resistance to aminoglycosides].
García-Vázquez E; Albendín H; Hernández-Torres A; Canteras M; Yagüe G; Ruiz J; Gómez J
Rev Esp Quimioter; 2013 Sep; 26(3):203-13. PubMed ID: 24080886
[TBL] [Abstract][Full Text] [Related]
20. A one-year prospective study of nosocomial bacteraemia in ICU and non-ICU patients and its impact on patient outcome.
Garrouste-Orgeas M; Chevret S; Mainardi JL; Timsit JF; Misset B; Carlet J
J Hosp Infect; 2000 Mar; 44(3):206-13. PubMed ID: 10706804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
